FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ullrich Bethe

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Oliver A Cornely; Angelika Böhme; Dietmar Reichert; Stefan Reuter; Georg Maschmeyer; Johan Maertens; Dieter Buchheidt; Monika Paluszewska; Dorothee Arenz; Ullrich Bethe; Jenny Effelsberg; Harry Lövenich; Michal Sieniawski; Antje Haas; Hermann Einsele; Hartmut Eimermacher; Rodrigo Martino; Gerda Silling; Moritz Hahn; Sidonie Wacker; Andrew J Ullmann; Meinolf Karthaus
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf Bechstein; John Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Laurence Collette; Michel Praet; Ullrich Bethe; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Manfred P Lutz; Hansjochen Wilke; D J Th Wagener; Udo Vanhoefer; Krzysztof Jeziorski; Susanna Hegewisch-Becker; Leopold Balleisen; Eric Joossens; Rob L Jansen; Muriel Debois; Ullrich Bethe; Michel Praet; Jacques A Wils; Eric Van Cutsem
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ullrich Bethe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Oliver A Cornely; Angelika Böhme; Dietmar Reichert; Stefan Reuter; Georg Maschmeyer; Johan Maertens; Dieter Buchheidt; Monika Paluszewska; Dorothee Arenz; Ullrich Bethe; Jenny Effelsberg; Harry Lövenich; Michal Sieniawski; Antje Haas; Hermann Einsele; Hartmut Eimermacher; Rodrigo Martino; Gerda Silling; Moritz Hahn; Sidonie Wacker; Andrew J Ullmann; Meinolf Karthaus
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
The Journal of antimicrobial chemotherapy 2008;61(4):939-46.
2008: Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf Bechstein; John Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Laurence Collette; Michel Praet; Ullrich Bethe; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Lancet 2008;371(9617):1007-16.
2007: Manfred P Lutz; Hansjochen Wilke; D J Th Wagener; Udo Vanhoefer; Krzysztof Jeziorski; Susanna Hegewisch-Becker; Leopold Balleisen; Eric Joossens; Rob L Jansen; Muriel Debois; Ullrich Bethe; Michel Praet; Jacques A Wils; Eric Van Cutsem
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(18):2580-5.
2005: H Lövenich; H Schütt-Gerowitt; C Keulertz; Dirk Waldschmidt; Ullrich Bethe; Dietmar Söhngen; Oliver A Cornely
Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.
Bone marrow transplantation 2005;35(10):997-1001.
2004: A Rothe; Michael Seibold; Th Hoppe; Harald Seifert; Andreas Engert; C Caspar; Meinolf Karthaus; Gerd Fätkenheuer; Ullrich Bethe; Kathrin Tintelnot; Oliver A Cornely
Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.
Annals of hematology 2004;83(6):394-7.
2004: Oliver A Cornely; Thomas Wicke; Harald Seifert; Ullrich Bethe; Martin Schwonzen; Dietmar Reichert; Andrew J Ullmann; Meinolf Karthaus; Kai Breuer; Bernd Salzberger; Volker Diehl; Gerd Fätkenheuer
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
International journal of hematology 2004;79(1):74-8.
2003: Hilmar Wisplinghoff; Oliver A Cornely; Susanne Moser; Ullrich Bethe; Hartmut Stützer; Bernd Salzberger; Gerd Fätkenheuer; Harald Seifert
Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(12):905-11.
2002: Felicitas C Kuehne; Ullrich Bethe; Kenneth Freedberg; Sue J Goldie
Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness.
Archives of internal medicine 2002;162(22):2545-56.
2002: Oliver A Cornely; Ullrich Bethe; Regina Pauls; Dirk Waldschmidt
Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(5):249-53.
2002: Oliver A Cornely; Ullrich Bethe; Harald Seifert; Kai Breuer; H Schütt-Gerowitt; Bernd Salzberger; Martin Schrappe; Gerd Fätkenheuer
A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
Annals of hematology 2002;81(1):37-43.
2001: Oliver A Cornely; Hendrik Pels; Ullrich Bethe; Michael Seibold; K Toepelt; D Soehngen; Andreas Ritzkowsky
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Bone marrow transplantation 2001;28(9):899-901.
2001: Oliver A Cornely; Ullrich Bethe; Bernd Salzberger; Caspar Franzen; Pia Hartmann; T Steinmetz; Gerd Fätkenheuer; Harald Seifert; Volker Diehl; Martin Schrappe
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
Annals of hematology 2001;80(2):103-8.
2000: Achim Schwenk; J P Breuer; Gisela Kremer; Katja Römer; Ullrich Bethe; Caspar Franzen; Gerd Fätkenheuer; Bernd Salzberger
Risk factors for the HIV-associated lipodystrophy syndrome in a cross-sectional single-centre study.
European journal of medical research 2000;5(10):443-8.
2000: Oliver A Cornely; Bernd Salzberger; Ullrich Bethe; Harald Seifert; Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Antibiotics and chemotherapy 2000;50():37-46.